These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12075735)

  • 1. Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.
    Schneeweiss A; Hensel M; Sinn P; Khbeis T; Haas R; Bastert G; Ho AD
    Ann Oncol; 2002 May; 13(5):679-88. PubMed ID: 12075735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.
    Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI
    J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection.
    Montemurro F; Rondón G; Munsell M; Smith TL; Donato ML; Gajewski JL; Rahman ZU; Buzdar AU; Champlin RE; Ueno NT
    Biol Blood Marrow Transplant; 2003 May; 9(5):330-40. PubMed ID: 12766883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
    Elias AD; Ibrahim J; Richardson P; Avigan D; Joyce R; Reich E; McCauley M; Wheeler C; Frei E
    Biol Blood Marrow Transplant; 2002; 8(4):198-205. PubMed ID: 12017145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of high-dose chemotherapy for breast cancer: a review.
    Nieto Y; Champlin RE; Wingard JR; Vredenburgh JF; Elias AD; Richardson P; Glaspy J; Jones RB; Stiff PJ; Bearman SI; Cagnoni PJ; McSweeney PA; LeMaistre CF; Pecora AL; Shpall EF
    Biol Blood Marrow Transplant; 2000; 6(5):476-95. PubMed ID: 11063377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
    Schneeweiss A; Hensel M; Goerner R; Khbeis T; Hohaus S; Egerer G; Solomayer E; Haas R; Grischke EM; Bastert G; Ho AD
    Stem Cells; 2001; 19(2):151-60. PubMed ID: 11239170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
    Ayash LJ; Wheeler C; Fairclough D; Schwartz G; Reich E; Warren D; Schnipper L; Antman K; Frei E; Elias A
    J Clin Oncol; 1995 Aug; 13(8):2043-9. PubMed ID: 7636547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support.
    Bewick M; Chadderton T; Conlon M; Lafrenie R; Morris D; Stewart D; Glück S
    Bone Marrow Transplant; 1999 Aug; 24(4):377-84. PubMed ID: 10467326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.
    Rancea M; Monsef I; von Tresckow B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD009411. PubMed ID: 23784872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.
    Vij R; DiPersio J; Brown R; Trinkaus K; Abboud C; Meehan KR; Frenette G; Freytes C; Goodnough LT; Khoury H; Ponnuri J; Adkins D
    Bone Marrow Transplant; 2000 Nov; 26(9):947-53. PubMed ID: 11100273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of high-dose chemotherapy and autologous stem-cell transplantation in stage IIIB inflammatory breast cancer.
    Adkins D; Brown R; Trinkaus K; Maziarz R; Luedke S; Freytes C; Needles B; Wienski D; Fracasso P; Pluard T; Moriconi W; Ryan T; Hoelzer K; Safdar S; Rearden T; Rodriguez G; Khoury H; Vij R; DiPersio J
    J Clin Oncol; 1999 Jul; 17(7):2006-14. PubMed ID: 10561251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California.
    Damon LE; Hu WW; Stockerl-Goldstein KE; Blume KG; Wolf JL; Gold E; Cecchi GR; Irwin D; Glaspy J; Territo I; Miller W; Mason JR; Linker CA
    Biol Blood Marrow Transplant; 2000; 6(5):496-505. PubMed ID: 11063378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
    Hensel M; Schneeweiss A; Sinn HP; Egerer G; Kornacker M; Solomayer E; Haas R; Bastert G; Ho AD
    Stem Cells; 2002; 20(1):32-40. PubMed ID: 11796920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.
    Montemurro F; Rondón G; Ueno NT; Munsell M; Gajewski JL; Champlin RE
    Bone Marrow Transplant; 2002 May; 29(10):861-6. PubMed ID: 12058236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
    Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH
    J Clin Oncol; 2017 Apr; 35(10):1096-1102. PubMed ID: 27870561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival after high-dose chemotherapy with autologous hematopoietic cell transplantation in metastatic breast cancer.
    Hamilton BK; Rybicki L; Abounader D; Andresen S; Kalaycio M; Sobecks R; Pohlman B; Hanna R; Dean R; Liu H; Hill B; Bolwell B; Copelan E
    Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):115-24. PubMed ID: 26183670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
    Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
    Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up after high-dose chemotherapy and autologous stem-cell transplantation for high-grade B-cell lymphoma suggests an improved outcome for high-risk patients with respect to the age-adjusted International Prognostic Index.
    Bertz H; Zeiser R; Lange W; Fetscher S; Waller CF; Finke J
    Ann Oncol; 2004 Sep; 15(9):1419-24. PubMed ID: 15319249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.
    Stemmler HJ; Salat C; Lindhofer H; Menzel H; Untch M; Kahlert S; Konecny G; Sauer H; Ledderose G; Heinemann V; Kolb HJ
    Anticancer Res; 2005; 25(4):3047-54. PubMed ID: 16080564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.